ROBERT PELLEGRINO: Open Payments
NPI 1235310186 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,052 in 31 payments from 11 companies in 2025. Trend: 2023 $1,131 · 2024 $788 · 2025 $1,052
Food & beverage: $1,052
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 1 | $523 |
| Novartis Pharmaceuticals Corporation | 6 | $108 |
| PFIZER INC. | 5 | $92 |
| Alnylam Pharmaceuticals Inc. | 5 | $92 |
| Amgen Inc. | 5 | $85 |
| Merck Sharp & Dohme LLC | 3 | $47 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| WATERMARK MEDICAL, INC. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: Rapiblyk, LEQVIO, VYNDAQEL, ONPATTRO, REPATHA, VERQUVO, AREXVY, EVKEEZA.
Industry payments across NJ — which companies pay providers there.
